TMEM247 Inhibitors
Chemical inhibitors of TMEM247 can interfere with its function through various mechanisms. Ouabain can lead to an altered ion gradient by inhibiting the Na+/K+-ATPase pump, which is crucial for maintaining the electrochemical gradient across the membrane that TMEM247 relies on for its activity. Amiloride disrupts sodium transport by inhibiting epithelial sodium channels, which can affect the electrochemical gradient and consequently, TMEM247 function. Glibenclamide, by inhibiting ATP-sensitive potassium channels, can destabilize the membrane potential, potentially inhibiting TMEM247 if its activity is dependent on a specific potassium-driven membrane potential. Similarly, Tetraethylammonium blocks potassium channels, which can alter the membrane potential and, thereby, TMEM247 function if it is sensitive to changes in the electrochemical conditions.
Verapamil, by blocking L-type calcium channels, can reduce intracellular calcium, a key secondary messenger, and thus can inhibit TMEM247 if it requires calcium for proper signaling. Brefeldin A disrupts protein transport from the ER to the Golgi, which could inhibit TMEM247 by preventing its proper localization or post-translational modifications necessary for function. Monensin, as an ionophore, disrupts intracellular ion gradients by allowing monovalent cations to flow across membranes, potentially disrupting the ion gradients TMEM247 depends on. Chlorpromazine integrates into cell membranes altering their properties, which can affect TMEM247 by changing the lipid microenvironment essential for its function. Niflumic acid inhibits chloride channels, which can affect TMEM247 if it relies on a chloride ion gradient. Phloretin inhibits glucose transporters, which can lead to changes in intracellular glucose levels that may affect TMEM247 activity indirectly. Progesterone can modulate TMEM247 by altering its structural conformation or its lipid microenvironment, whereas Clofilium tosylate, another potassium channel blocker, can inhibit TMEM247 by affecting the voltage across the plasma membrane.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+-ATPase pump which could result in altered ion gradients. TMEM247, being a transmembrane protein, may rely on proper membrane potential and ion gradients for its function. Inhibition of Na+/K+-ATPase can lead to inhibition of TMEM247 by disrupting its ionic environment essential for its conformation and activity. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is an inhibitor of epithelial sodium channels (ENaCs). It alters sodium transport across membranes, potentially affecting the electrochemical gradient. TMEM247 function can be inhibited due to the disruption of the sodium gradient that it may utilize for its transport mechanism or signaling function. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
Glibenclamide inhibits ATP-sensitive potassium channels. Should TMEM247 require a potassium-dependent membrane potential for its function, inhibition of these channels by Glibenclamide can lead to functional inhibition of TMEM247 by destabilizing the membrane potential necessary for its activity. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that can inhibit L-type calcium channels, leading to decreased intracellular calcium. Since calcium is a crucial secondary messenger, inhibition of calcium influx can inhibit TMEM247 by preventing calcium-dependent signaling pathways that TMEM247 is involved in from functioning properly. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function and can inhibit protein transport from the ER to the Golgi. TMEM247 could require proper glycosylation and trafficking to the membrane to be functional. Inhibition of this process by Brefeldin A can lead to the functional inhibition of TMEM247 by mislocalization or improper post-translational modification. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts intracellular ion gradients by allowing the flow of monovalent cations across membranes. TMEM247, being a transmembrane molecule, may rely on controlled ion gradients for its activity. By equilibrating ion concentrations, Monensin can inhibit TMEM247 by perturbing the ion gradients necessary for its activity. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a cationic amphiphilic drug known to inhibit a variety of cellular functions by integrating into cell membranes and altering their properties. It can inhibit TMEM247 by changing the membrane dynamics and lipid microenvironments, which are critical for the function of transmembrane proteins. | ||||||
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid inhibits chloride channels, which could affect TMEM247 by altering the chloride ion gradient across the plasma membrane. Disruption of this gradient can lead to functional inhibition of TMEM247 if its activity is chloride-dependent. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin inhibits various glucose transporters, potentially decreasing intracellular glucose levels. If TMEM247 function is coupled to intracellular glucose levels or the activity of these transporters, Phloretin can inhibit TMEM247 by interfering with these metabolic processes. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
Progesterone has been shown to modulate (inhibit or activate depending on the context) certain ion channels and membrane receptors. It can inhibit TMEM247 by binding to regulatory sites on or near TMEM247, altering its conformation or the lipid microenvironment in which TMEM247 operates, thus inhibiting its function. | ||||||